✦ LIBER ✦

Prevalence of adverse events during combination therapy, interferon a-2b and ribavirine, for chronic viral hepatitis C

✍ Scribed by Herve, Sophie; Varin, Remi; Savoye, Guillaume; Riachi, Ghassan; Goria, Odile; Donnadieu, Nathalie; Colin, Raymond

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neutropenia during combination therapy o

✍ Alejandro Soza; James E. Everhart; Marc G. Ghany; Edward Doo; Theo Heller; Kitti 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Combination Therapy with Interferon-α2b,

✍ Paul J. Thuluvath; Hemant Pande; Joyce Maygers 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 29 KB

Eicosapentaenoic Acid Supplementation fo

✍ Aiko Kawashima; Ikuyo Tsukamoto; Tomoko Koyabu; Yasuko Murakami; Takayo Kawakami 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 255 KB

Changes in haemoglobin during interferon

✍ M. S. Sulkowski; R. Wasserman; L. Brooks; L. Ball; R. Gish 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Combination therapy with interferon alfa

✍ Hemant Pande; Paul J Thuluvath; Salim A Jaffer; Joyce Maygers 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 28 KB

Factors contributing to ribavirin dose r

✍ Shintaro Takaki; Akihito Tsubota; Tetsuya Hosaka; Norio Akuta; Takashi Someya; M 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 209 KB